Cat: IPD-X35706

Recombinant Human CD161/KLRB1 Protein (HEK293),Avi & His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    CD161/KLRB1

  • 简介

    CD161 protein plays a crucial role in inhibiting NK cell toxicity by activating specific acid sphingomyelinase/SMPD1 and increasing ceramide levels. Activation stimulates AKT1/PKB and RPS6KA1/RSK1 kinases, enhancing anti-CD3-induced T cell proliferation. CD161 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD161 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    1.Immobilized Biotinylated Human CD161 His at 1 μg/mL (100 μL/Well) on the plate. Dose response curve for Anti-CD161 Antibody hFc with the EC50 < 9.3 ng/mL determined by ELISA. 2.Immobilized Ant-CD161 Anlibody,hFc Tag at 5 μg/mL (100 μL/Well)on the plate. Dose response curve for Biotinylated Human CD161,His Tag with the EC50 ≤ 28.9 ng/mL detormined by ELISA. 3. Loaded Rezorstobart (HY-P990760) on AHC2 biosensor, can bind CD161 Protein, Human (Biotinylated, HEK293, His-Avi) with an affinity constant of 3.766E-10 M as determined in BLI assay. Loaded Rezorstobart (HY-P990760) on AHC2 biosensor, can bind CD161 Protein, Human (Biotinylated, HEK293, His-Avi) with an affinity constant of 3.766E-10 M as determined in BLI assay.

  • Alternative Names

    KLRB1; CLEC5B; NKRP1A; NKR-P1A; HNKR-P1a; CD161; Ly59; NKR; NKRP1; NKR-P1; NKRP1ANKR

  • Species

    Human

  • Source

    HEK293

  • Tag

    C-Avi;C-8*His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q12918

  • Expression Region

    Q67-S225

  • Protein Length

    Extracellular Domain

  • Molecular Weight

    35-43 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

CD161, also known as KLRB1, is an activating receptor primarily expressed on natural killer (NK) cells and some T lymphocytes, playing a critical role in immune regulation and response. Its engagement with ligands modulates immune cell activation and cytokine production, highlighting its importance in immune surveillance and defense against various pathogens and tumors. Research into the CD161/KLRB1 recombinant protein has gained momentum as scientists aim to elucidate its precise biological functions and therapeutic potential. The recombinant form allows for the study of protein structure, binding interactions, and signal transduction pathways in a controlled environment, facilitating advancements in NK cell biology and immunotherapy. Furthermore, understanding the role of CD161 in immune evasion mechanisms in cancers can lead to novel treatment strategies that enhance anti-tumor immunity. Investigating the efficacy of CD161-targeted therapies, such as bispecific antibodies or chimeric antigen receptor (CAR) NK cells, represents a promising frontier in cancer immunotherapy. Overall, the characterization of CD161/KLRB1 recombinant proteins is pivotal for developing innovative approaches to harness and enhance immune responses in both infectious diseases and malignancies.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US